These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4145040)

  • 41. Differentiation of antigenic markers on B cells and on antibody-forming cells.
    McKenzie IF; Elliott BE; Haskill JS
    Isr J Med Sci; 1975 Dec; 11(12):1278-84. PubMed ID: 56321
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of effect of four cytotoxic agents on granulocytic and erythroid repopulating ability of rat bone marrow.
    Constable TB; Blackett NM
    J Natl Cancer Inst; 1972 Apr; 48(4):941-8. PubMed ID: 4554117
    [No Abstract]   [Full Text] [Related]  

  • 43. Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Davis BM; Reese JS; Koç ON; Lee K; Schupp JE; Gerson SL
    Cancer Res; 1997 Nov; 57(22):5093-9. PubMed ID: 9371508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effects of cyclophosphamide, isophosphamide, 4-methylcyclophosphamide, and phosphoramide mustard on murine hematopoietic and immunocompetent cells.
    Sensenbrenner LL; Marini JJ; Colvin M
    J Natl Cancer Inst; 1979 Apr; 62(4):975-81. PubMed ID: 285298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.
    Otterness IG; Chang YH
    Clin Exp Immunol; 1976 Nov; 26(2):346-54. PubMed ID: 991462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells.
    Bohunická E; Koza I; Kuzela S; Krempaský V; Ujházy V
    Neoplasma; 1972; 19(5):499-505. PubMed ID: 4404912
    [No Abstract]   [Full Text] [Related]  

  • 47. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 48. A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents.
    Botnick LE; Hannon EC; Hellman S
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1621-5. PubMed ID: 395140
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide.
    Ghaffar A; James K
    Immunology; 1973 Jun; 24(6):1075-85. PubMed ID: 4146227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mathematical modelling of the action of methotrexate on the kinetics of B-lymphocyte proliferation during the primary response].
    Loginov AV; Uteshev BS; Livshits MA
    Farmakol Toksikol; 1987; 50(2):58-70. PubMed ID: 3495455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunosuppression and ablastin.
    Dusanic DG
    Exp Parasitol; 1975 Dec; 38(3):322-37. PubMed ID: 1107052
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of hapten-immunosuppressive agent complexes on the immune reaction].
    Malberg K; Drössler K; Ambrosius H
    Allerg Immunol (Leipz); 1973; 19(2-4):342-8. PubMed ID: 4141870
    [No Abstract]   [Full Text] [Related]  

  • 53. Peritoneal exudate mononuclear phagocyte colony-forming cells: their proliferative state in vivo and sensitivity to cytotoxic agents.
    Lin HS
    Cell Tissue Kinet; 1980 Jul; 13(4):395-401. PubMed ID: 7428013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice.
    Lemmel EM; Motycka K; Soucek J; Nouza K
    Arzneimittelforschung; 1967 Feb; 17(2):142-5. PubMed ID: 4173310
    [No Abstract]   [Full Text] [Related]  

  • 55. Antibody production in mice. 3. The suppressive effect of antibody on the initiation of secondary immune response.
    Hamaoka T; Takatsu K; Masaki H; Matsuoka Y; Kitagawa M
    Immunology; 1971 Jun; 20(6):871-81. PubMed ID: 5558029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H; Good RA
    Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ability of antilymphocyte sera to counteract the allogeneic inhibition of hematopoietic stem cells].
    Golovistikov IN
    Dokl Akad Nauk SSSR; 1975 Aug; 223(5):1245-7. PubMed ID: 222
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of actinomycin on the kinetics of a population of antibody-producing cells].
    Uteshev BS; Pinegin BV; Babichev VA; Torchinskiĭ GA
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Mar; 47(3):103-8. PubMed ID: 4099680
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hemopoietic stem cells and antitumoral drugs. 1. Variations of in vitro and in vivo colony forming cells following single dose administration of cyclophosphamide, vinblastine and azathioprine (author's transl)].
    Pannacciulli I; Ghio R; Bogliolo G; Massa G; Saviane A; Bianchi G
    Haematologica; 1976 Dec; 61(4):432-8. PubMed ID: 828607
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of biopreparation cACPL on the proliferative activity of haemopoietic and tumour cells.
    Jurásková V
    Folia Biol (Praha); 1988; 34(3):192-201. PubMed ID: 3203819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.